BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37867522)

  • 1. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
    Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
    Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
    Gibril F; Schumann M; Pace A; Jensen RT
    Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
    Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
    Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome.
    Verschuur AVD; Kok ASM; Morsink FHM; de Leng WWJ; van den Broek MFM; Koudijs MJ; Offerhaus JA; Valk GD; Vriens MR; van Nesselrooij BPM; Hackeng WM; Brosens LAA
    Am J Surg Pathol; 2023 Jul; 47(7):785-791. PubMed ID: 37199453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
    Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
    Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
    Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
    World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
    Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
    Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
    Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
    McCarthy DM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
    Thakker RV
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
    Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
    Bartsch DK; Fendrich V; Langer P; Celik I; Kann PH; Rothmund M
    Ann Surg; 2005 Dec; 242(6):757-64, discussion 764-6. PubMed ID: 16327485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.